IL6 and breast cancer: Interestingly, exosomal miR-9 and miR-181a were reported to promote breast cancer through the activation of the JAK/STAT signaling pathway and increasing the production of early myeloid-derived suppressor cells that express significant levels of IL-6 (Jiang et al., 2020).